- Home
- ATRA vs AHT Comparison
ATRA vs AHT Comparison
Compare ATRA & AHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATRA
- AHT
- Stock Information
- Founded
- ATRA 2012
- AHT 2003
- Country
- ATRA United States
- AHT United States
- Employees
- ATRA N/A
- AHT N/A
- Industry
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- AHT Real Estate Investment Trusts
- Sector
- ATRA Health Care
- AHT Real Estate
- Exchange
- ATRA Nasdaq
- AHT Nasdaq
- Market Cap
- ATRA 32.4M
- AHT 33.9M
- IPO Year
- ATRA 2014
- AHT 2003
- Fundamental
- Price
- ATRA $6.17
- AHT $6.17
- Analyst Decision
- ATRA Buy
- AHT
- Analyst Count
- ATRA 5
- AHT 0
- Target Price
- ATRA $17.75
- AHT N/A
- AVG Volume (30 Days)
- ATRA 47.4K
- AHT 27.9K
- Earning Date
- ATRA 05-08-2025
- AHT 05-06-2025
- Dividend Yield
- ATRA N/A
- AHT N/A
- EPS Growth
- ATRA N/A
- AHT N/A
- EPS
- ATRA N/A
- AHT N/A
- Revenue
- ATRA $128,940,000.00
- AHT $1,170,089,000.00
- Revenue This Year
- ATRA N/A
- AHT N/A
- Revenue Next Year
- ATRA N/A
- AHT N/A
- P/E Ratio
- ATRA N/A
- AHT N/A
- Revenue Growth
- ATRA 1404.02
- AHT N/A
- 52 Week Low
- ATRA $5.01
- AHT $5.20
- 52 Week High
- ATRA $19.00
- AHT $13.90
- Technical
- Relative Strength Index (RSI)
- ATRA 47.91
- AHT 38.08
- Support Level
- ATRA $5.16
- AHT $5.61
- Resistance Level
- ATRA $6.11
- AHT $6.01
- Average True Range (ATR)
- ATRA 0.61
- AHT 0.44
- MACD
- ATRA 0.08
- AHT -0.03
- Stochastic Oscillator
- ATRA 78.98
- AHT 40.09
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).
About AHT Ashford Hospitality Trust Inc
Ashford Hospitality Trust Inc. is a real estate investment trust that invests in full-service upscale and upper-upscale hotel properties in the U.S. The company owns and operates its assets through its operating partnership, Ashford Hospitality Limited Partnership. All of its hotels are located across the U.S. and operate under the Marriott, Hilton, Hyatt, Crowne Plaza, and Sheraton brands. Ashford's sole segment is Direct Hotel Investments, through which it owns hotels by acquisition or development. Ashford also provides real estate investment services, such as mezzanine financing, first mortgage financing, and sales-leaseback transactions. Its revenue streams include Room revenue, Food and beverage revenue, and Other revenue. Room revenue accounts for the majority of total revenue.